Testican 3 expression in adult T-cell leukemia

Leukemia Research

Volumn 33, Issue 7, 2009, Pages 913-918

  Kamioka, Mikio ^a   Imamura, Jun ^a   Komatsu, Naoki ^a   Daibata, Masanori ^a   Sugiura, Tetsuro ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Activating transcriptional factor 3; Adult T cell leukemia; Human T lymphotropic virus type I; Testican 3

Indexed keywords

CD147 ANTIGEN; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; TESTICAN 3; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR III; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LEUKEMIA;

ACTIVATING TRANSCRIPTION FACTOR 3; ADULT; ANISOMYCIN; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROTEIN SYNTHESIS INHIBITORS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 67349199993     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.11.006     Document Type: Article

References (22)

1. Elkington P.T.G., O'Kane C.M., and Friedland J.S. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 142 (2005) 12-20
2. Egawa N., Koshikawa N., Tomari T., Nabeshima K., Isobe T., and Seiki M. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. J Biol Chem 281 (2006) 37576-37585
3. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294 (1981) 770-771
4. Nabeshima K., Suzumiya J., Nagano M., Ohshima K., Toole B.P., Tamura K., et al. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J Pathol 202 (2004) 341-351
5. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K.I., et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78 (1981) 6476-6480
6. Nakada M., Yamada A., Takino T., Miyamori H., Takahashi T., Yamashita J., et al. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product N-Tes. Cancer Res 61 (2001) 8896-8902
7. Hai T.W., Liu F., Coukos W.J., and Green M.R. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev 3 (1989) 2083-2090
8. Koyanagi Y., Hinuma Y., Schneider J., Chosa T., Hunsmann G., Kobayashi N., et al. Expression of HTLV-specific polypeptides in various human T-cell lines. Med Microbiol Immunol 173 (1984) 127-140
9. Hoshino H., Esumi H., Miwa M., Shimoyama M., Minato K., Tobinai K., et al. Establishmentand characterization of 10 cell lines derived from patients with adult T-cell leukemia. Proc Natl Acad Sci USA 80 (1983) 6061-6065
10. Diatchenko L., Lau Y.F., Campbell A.P., Chenchik A., Moqadam F., Huang B., et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93 (1996) 6025-6030
11. Wang A., Doyle M., and Mark M. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86 (1989) 9717-9721
12. Mori N., Sato H., Hayashibara T., Senba M., Hayashi T., Yamada Y., et al. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. Blood 99 (2002) 1341-1349
13. Pelisch F., Blaustein M., Kornblihtt A.R., and Srebrow A. Cross-talk between signaling pathways regulates alternative splicing: a novel role for JNK. J Biol Chem 280 (2005) 25461-25469
14. Lu D., Chen J., and Hai T. The regulation of ATF3 gene expression by mitogen-activated protein kinases. Biochem J 15 (2007) 559-567
15. Hinuma Y., Komoda H., Chosa T., Kondo T., Kohakura M., Takenaka T., et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer 29 (1982) 631-635
16. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., and Calender A. Antibodies to human T-lymphotropic virus type I in patients with tropic spastic paraparesis. Lancet 2 (1985) 407-410
17. Bazarbachi A., Merhi R.A., Gessain A., Talhouk R., El-Khoury H., Nasr R., et al. Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism. Cancer Res 64 (2004) 2039-2046
18. Giraudon P., Szymocha R., Buart S., Bernard A., Cartier L., Belin M.F., et al. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease. J Immunol 164 (2000) 2718-2727
19. Gilchrist M., Thorsson V., Li B., Rust A.G., Korb M., Kennedy K., et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441 (2006) 173-178
20. Janz M., Hummel M., Truss M., Wollert-Wulf B., Mathas S., Jöhrens K., et al. Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcriptional factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Strenberg cells. Blood 107 (2006) 2536-2539
21. Low K.G., Chu H.M., Schwartz P.M., Daniels G.M., Melner M.H., and Comb M.J. Novel interactions between human T-cell leukemia virus type I Tax and activating transcription factor 3 at a cyclic AMP-responsive element. Mol Cell Biol 14 (1994) 4958-4974
22. Lemasson I., Lewis M.R., Polakowski N., Hivin P., Cavanagh M.H., Thébault S., et al. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol 81 (2007) 1543-1553